🇺🇸 FDA
Patent

US 8609848

Pyrazolone-derivatives and their use as PDE-4 inhibitors

granted A61PA61P11/00A61P11/02

Quick answer

US patent 8609848 (Pyrazolone-derivatives and their use as PDE-4 inhibitors) held by TAKEDA GMBH expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P11/00, A61P11/02, A61P11/06, A61P11/08